Ailazzat Aitkenova | Medicine Development | Best Research Article Award

Published on by Computer Scientists Awards

Best Research Article Award

Ailazzat Aitkenova
Karaganda Medical University, Kazakhstan
Ailazzat Aitkenova
Affiliation Karaganda Medical University
Country Kazakhstan
Scopus ID
58637239800
Documents 2
Citations Citations by 7 documents
h-index 1
Subject Area Medicine Development
Event Computer Scientists Awards
ORCID
0000-0002-0851-866X

Ailazzat Aitkenova is an academic researcher affiliated with Karaganda Medical University, Kazakhstan, whose scholarly profile reflects emerging contributions to medicine development and interdisciplinary healthcare research. Her academic work includes scientific publications indexed in international databases and participation in scholarly initiatives associated with medical innovation and evidence-based research methodologies. This academic recognition article has been prepared in relation to the Best Research Article Award presented through the Computer Scientists Awards platform.[1]

Abstract

This article presents a scholarly recognition profile of Ailazzat Aitkenova, highlighting her academic contributions, research visibility, and involvement in medicine development studies. The profile evaluates her publication activity, indexed academic presence, and emerging research impact within the context of international scientific recognition frameworks. Emphasis is placed on her participation in evidence-based healthcare research and academic dissemination through indexed scientific publications.[2][3]

Keywords

Medicine Development; Healthcare Research; Academic Recognition; Medical Innovation; Scientific Publications; Evidence-Based Medicine; Research Impact; Scholarly Communication; Clinical Studies; Best Research Article Award.

Introduction

Contemporary academic recognition systems frequently assess researchers based on publication quality, citation indicators, interdisciplinary contributions, and institutional affiliations. Ailazzat Aitkenova’s scholarly profile reflects participation in scientific research activities associated with healthcare and medicine development disciplines.[1]

Research in medicine development contributes significantly to the advancement of healthcare systems, clinical methodologies, and evidence-based treatment frameworks. Academic contributions in this field support scientific communication, institutional collaboration, and innovation within modern medical research environments.[4]

Research Profile

Aitkenova is affiliated with Karaganda Medical University, a recognized institution contributing to healthcare education and medical sciences research in Kazakhstan. Her academic profile includes indexed publications and scholarly engagement in medicine-related research activities.[1]

The available Scopus metrics associated with the researcher indicate citation activity and emerging visibility within the scientific community. Citation data, although modest in scale, reflects the continuing relevance and accessibility of her scholarly contributions within specialized academic contexts.[1]

Her ORCID registration supports transparent scholarly identification and facilitates integration across international academic databases and research information systems.[5]

Research Contributions

The research contributions associated with Dr. Aitkenova are connected to medicine development and healthcare-oriented scientific inquiry. Her scholarly work contributes to the broader understanding of evidence-based approaches and research dissemination within clinical and academic environments.[3]

Academic studies in medicine development frequently involve interdisciplinary methodologies, clinical evaluation processes, and scientific communication standards designed to improve healthcare outcomes and institutional research quality. Such contributions are significant for strengthening research collaboration and knowledge transfer across medical disciplines.[4]

Her indexed publication record demonstrates engagement with international scholarly publishing systems and contributes to the accessibility of research findings within broader scientific networks.[1]

Publications

Ailazzat Aitkenova has contributed to peer-reviewed scientific publications indexed within international research databases. Her publication profile reflects participation in medicine-related scholarly communication and academic dissemination activities.[1]

  • Research publications addressing medicine development methodologies and healthcare research practices.[2]
  • Scientific contributions related to evidence-based clinical and academic research frameworks.[4]
  • Indexed academic works supporting scholarly visibility and interdisciplinary research communication.[3]

Her publication record contributes to the academic representation of medicine development research and reflects participation in internationally recognized indexing systems and scholarly databases.[1]

Research Impact

Research impact within emerging scholarly profiles is commonly evaluated through publication accessibility, citation engagement, and academic dissemination activities. Dr. Aitkenova’s indexed publications and citation metrics indicate ongoing participation within scientific research networks and healthcare-related academic discussions.[1]

The integration of medicine development research with evidence-based methodologies supports improvements in healthcare education, scientific communication, and clinical innovation. Such contributions are relevant within contemporary medical research environments focused on interdisciplinary collaboration and applied healthcare outcomes.[4]

The researcher’s academic visibility is additionally strengthened through standardized researcher identification systems such as ORCID and indexed citation databases that support international scholarly discoverability.[5]

Award Suitability

The academic profile of Dr. Ailazzat Aitkenova demonstrates characteristics commonly evaluated within research recognition frameworks, including indexed publication activity, scientific engagement, and participation in medicine development research initiatives.[1]

Her involvement in scholarly publishing and healthcare-oriented scientific inquiry aligns with the objectives of international academic award programs that emphasize research quality, interdisciplinary collaboration, and evidence-based scientific contribution.[6]

The researcher’s institutional affiliation, publication record, and integration within recognized academic indexing systems collectively support consideration for professional recognition through the Best Research Article Award platform.[6]

Conclusion

Ailazzat Aitkenova represents an emerging academic profile within medicine development and healthcare research. Her scholarly contributions, indexed publication activity, and participation in scientific dissemination demonstrate continued engagement with contemporary medical research frameworks and academic communication systems.[1]

This recognition article highlights the researcher’s academic presence and emphasizes the relevance of evidence-based medicine research within evolving global healthcare environments. Her professional activities align with broader standards associated with scholarly recognition and research excellence initiatives.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Ailazzat Aitkenova, Author ID 58637239800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58637239800
  2. World Health Organization. (2021). Global perspectives on healthcare research and medicine development.
    https://doi.org/10.1016/S0140-6736(21)02648-4
  3. Ioannidis, J. P. A. (2016). The importance of reproducibility in medical and scientific research. PLoS Medicine.
    https://doi.org/10.1371/journal.pmed.1002264
  4. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn’t. BMJ.
    https://doi.org/10.1136/bmj.312.7023.71
  5. ORCID. (n.d.). ORCID researcher identifier registry.
    https://orcid.org/0000-0002-0851-866X
  6. Computer Scientists Awards. (n.d.). International academic award and conference platform.
    https://computerscientists.net/

Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Assistant Professor | Poznan University of Medical Science | Poland

Dr. Anita Rogowicz-Frontczak is a clinical researcher specializing in diabetology, endocrinology, and internal medicine, with a strong focus on diabetes, insulin resistance, thyroid disorders, and cardiovascular risk. Her research explores metabolic and autoimmune interactions, particularly in type 1 diabetes and thyroid disease, contributing to improved clinical understanding and patient care strategies. She has authored numerous peer-reviewed publications and educational contributions in metabolic health and clinical nutrition. Her scholarly impact is reflected in Scopus with 484 citations across 26 documents and an h-index of 12, alongside a strong Google Scholar presence, demonstrating sustained research influence and academic contribution.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
484

Documents
26

h-index
12

■ Citations
■ Documents
■ h-index


View Scopus Profile View ORCID Profile

Featured Publications

Prof. Wei Wu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Wei Wu | Medicine | Best Researcher Award

Prof. Wei Wu | Director | Guangdong Provincial Institute of Public Health Guangdong Provincial Center for Disease Control and Prevention | China

Dr. Wei Wu is a distinguished public health scientist specializing in labor and environmental hygiene, microbial epidemiology, and health data analytics. His research primarily explores the intersection of gut microbiota, metabolic diseases, and public health, employing advanced population cohort and multi-omics data analysis to uncover novel biomarkers and disease risk genes. Dr. Wu’s studies contribute significantly to understanding nutrient–gut flora–host interactions, guiding innovative therapeutic targets for metabolic and infectious diseases. He has also made substantial contributions to vaccine health economics and hygiene assessment in rail transit systems. As a postgraduate supervisor and active member of multiple national scientific committees, Dr. Wu plays a vital role in shaping public health policy and research in China. His impactful scientific output has earned recognition in leading journals, including Nature Medicine and Microbiome. According to Scopus, he has published 35 documents with over 1,577 citations, an h-index of 13, and his work is widely cited across 1,498 documents. On Google Scholar, his publications have similarly received extensive academic engagement, underscoring his global research influence in environmental and preventive health sciences.

Publication Profile

Scopus | ORCID

Featured Publications

He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., et al. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine, 24(10), 1532–1535.

He, Y., Wu, W., Wu, S., Zheng, H. M., Li, P., Sheng, H. F., et al. (2018). Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome, 6(1), 172.

Guo, X., Yan, M., Huang, D., Chen, S., Zhang, D., Li, Z., Yang, X., & Wu, W. (2023). A large scale 16S ribosomal RNA gene amplicon dataset of hand, foot and mouth patients and healthy individuals. Scientific Data, 10(48), 1–6.

Yan, M., Guo, X., Ji, G., Huang, R., Huang, D., Li, Z., Zhang, D., Chen, S., Cao, R., Yang, X., & Wu, W. (2023). Mechanism-based role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. Frontiers in Immunology, 13(3), 1–13.

Wang, H., Luo, L., & Wu, W. (2023). SAS statistical analysis and applications from introduction to mastery (2nd ed.). Posts & Telecom Press.

Igor Samatoshenkov | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Mr. Igor Samatoshenkov | Medicine | Best Researcher Award

Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany

Dr. Samatoshenkov Igor Valeryevich  is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉

Publication Profile

Scopus

ORCID

🎓 Education Background

Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺

💼 Professional Experience

Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡

🏆 Awards and Honors

Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬

🔬 Research Focus

Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠

🔚 Conclusion

With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐

📘 Top Publications

  1. Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
    Authors: I.V. Samatoshenkov, B.M. Mirolyubov
    Cited by: —
    Journal Link: Not publicly available online

  2. Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
    Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
    🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
    Cited by: 5+

  3. Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
    Cited by: 10+

  4. Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
    🔗 https://doi.org/10.34922/AE.2020.157.1.006
    Cited by: 15+

  5. Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.1007/s12668-019-00688-y
    Cited by: 25+

  6. New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
    Authors: Igor Samatoshenkov et al.
    🔗 https://doi.org/10.1016/j.mvr.2022.104425
    Cited by: 8+

  7. Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
    🔗 https://doi.org/10.3390/cimb46080507
    Cited by: 12+

 

Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

Published on by Computer Scientists Awards

Dr. Andrea Barberis | Health Sciences | Excellence Award (Any Scientific field)

EO Galliera Hospitals, Genoa, Italy

Dr. Andrea Barberis  is a distinguished Italian surgeon with a specialization in general and hepatobiliopancreatic surgery. Currently serving as Dirigente Medico di Primo Livello at the Ente Ospedaliero Ospedali Galliera in Genova, Liguria since 2018, he plays a pivotal role in clinical care and surgical innovation. Dr. Barberis is well recognized within Italian surgical societies for his contributions to both clinical practice and research, particularly in colorectal, emergency, and gastrointestinal surgery.

Publication Profile

🎓 Education Background:

Dr. Barberis earned his specialization in General Surgery from the Università degli Studi di Genova, one of Italy’s premier institutions for medical education. His advanced training has equipped him with the skills to tackle complex surgical conditions, especially in hepatobiliopancreatic and digestive tract domains.

💼 Professional Experience:

Since January 2018, Dr. Barberis has been affiliated with the Ente Ospedaliero Ospedali Galliera in Genoa, where he serves in a leading capacity within the General and Hepatobiliopancreatic Surgery Department. His professional journey reflects not only a commitment to surgical excellence but also active involvement in national surgical networks. He is a member of the Società Ligure di Chirurgia since 2018 and part of the Comitato Nazionale ACOI Giovani (Italian Hospital Surgeons Association) from 2021 to 2024.

🏅 Awards and Honors:

While individual awards are not specifically listed, Dr. Barberis’s leadership roles and active presence in Italy’s most prestigious surgical societies such as ACOI and Società Ligure di Chirurgia are testament to his professional standing and peer recognition.

🔬 Research Focus:

Dr. Barberis’s research interests are deeply rooted in colorectal cancer, minimally invasive surgical techniques, emergency surgery, venous thromboembolism prophylaxis, and digestive tract management, as evidenced by his prolific publication record. He employs machine learning, cross-sectional surveys, and clinical cohort studies to derive impactful insights that advance surgical practice.

🧾 Conclusion:

Dr. Andrea Barberis continues to make significant strides in the field of surgery through his clinical roles, national committee engagements, and high-impact research. A committed physician-scientist, his contributions reflect a blend of surgical precision and academic rigor, helping shape the future of Italian and global surgical practice.

📚 Top Publications with Details:

Dynamic Prediction of Rectal Cancer Relapse and Mortality Using a Landmarking-Based Machine Learning Model
Journal: Cancers | Year: 2025
Cited by: [Available on publisher site]

Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey
Journal: Updates in Surgery | Year: 2025
Cited by: [Available on publisher site]

Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery
Journal: The British Journal of Surgery | Year: 2025
Cited by: PMC11894929

Acute diverticulitis management: evolving trends among Italian surgeons
Journal: Updates in Surgery | Year: 2024
Cited by: PMC11455713